Clinical Trial Update: A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 pharmacokinetic study in healthy volunteers to compare four modified-release formulations of dimebon (latrepirdine). The study is ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer's Disease, Huntington Disease | Phase 1 | Status: COMPLETED